Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Article in Cancer Biology & Medicine (May 2022)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in Cancer Biology & Medicine (May 2022)
Article in Journal of Experimental & Clinical Cancer Research (April 2022)
Article in Scientific Reports (February 2020)